Logo image of MTNB

MATINAS BIOPHARMA HOLDINGS I (MTNB) Stock Analyst Ratings

USA - NYSE Arca - NYSEARCA:MTNB - US5768103039 - Common Stock

0.7202 USD
-0.03 (-3.97%)
Last: 12/1/2025, 12:44:39 PM
Buy % Consensus

46

ChartMill assigns a Buy % Consensus number of 46% to MTNB. The Buy consensus is the weighted average rating of the current analysts ratings.

MTNB was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about MTNB.
In the previous month the buy percentage consensus was at a similar level.
MTNB was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

MTNB Historical Analyst RatingsMTNB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -105 -95 -85 -75 -65 -55 -45 -35 -25 -15 -5 2 4 6 8 10

Related screens

MTNB Current Analyst RatingMTNB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-10-31 Maxim Group Downgrade Buy -> Hold
2023-10-11 BTIG Reiterate Buy -> Buy
2023-01-31 HC Wainwright & Co. Reiterate Buy

MATINAS BIOPHARMA HOLDINGS I / MTNB FAQ

How do analysts rate MATINAS BIOPHARMA HOLDINGS I (MTNB)?

The consensus rating for MATINAS BIOPHARMA HOLDINGS I (MTNB) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.